Envista (NVST) – Research Analysts’ Recent Ratings Changes

A number of firms have modified their ratings and price targets on shares of Envista (NYSE: NVST) recently:

• 5/3/2024 – Envista had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $17.50. They now have a “sell” rating on the stock.
• 5/2/2024 – Envista had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $23.00. They now have an “overweight” rating on the stock.
• 5/2/2024 – Envista had its price target lowered by analysts at Robert W. Baird from $22.00 to $19.00. They now have a “neutral” rating on the stock.
• 5/2/2024 – Envista had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 4/26/2024 – Envista was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $21.00 price target on the stock, down previously from $33.00.

Envista Trading Up 1.6 %

NYSE NVST opened at $18.64 on Thursday. The stock has a market capitalization of $3.20 billion, a P/E ratio of -25.88, a P/E/G ratio of 14.56 and a beta of 1.35. Envista Holdings Co. has a 52-week low of $17.90 and a 52-week high of $36.14. The firm has a 50-day moving average price of $20.05 and a 200 day moving average price of $22.07. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.34.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.05). The firm had revenue of $623.60 million for the quarter, compared to analysts’ expectations of $634.85 million. Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the company earned $0.38 earnings per share. Equities research analysts expect that Envista Holdings Co. will post 1.26 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Swedbank AB acquired a new stake in shares of Envista in the first quarter valued at approximately $53,412,000. Tidal Investments LLC grew its position in shares of Envista by 105.1% in the first quarter. Tidal Investments LLC now owns 20,331 shares of the company’s stock valued at $435,000 after purchasing an additional 10,420 shares during the last quarter. Invenomic Capital Management LP grew its position in shares of Envista by 24.9% in the first quarter. Invenomic Capital Management LP now owns 481,558 shares of the company’s stock valued at $10,296,000 after purchasing an additional 96,090 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Envista by 6.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 133,887 shares of the company’s stock worth $2,863,000 after acquiring an additional 8,380 shares during the last quarter. Finally, Quadrature Capital Ltd boosted its position in Envista by 110.9% during the first quarter. Quadrature Capital Ltd now owns 69,004 shares of the company’s stock worth $1,476,000 after acquiring an additional 36,290 shares during the last quarter.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.